[	0	0
Experimental	1	12
and	14	16
clinical	18	25
studies	27	33
of	35	36
flomoxef	38	45
in	47	48
the	50	52
field	54	58
of	60	61
obstetrics	63	72
and	74	76
gynecology	78	87
.	88	88

Representative	90	103
Committee	105	113
Members	115	121
of	123	124
the	126	128
Research	130	137
Team	139	142
for	144	146
Infections	148	157
in	159	160
the	162	164
Field	166	170
of	172	173
Obstetrics	175	184
and	186	188
Gynecology	190	199
]	200	200
.	201	201

Flomoxef	203	210
(	212	212
FMOX	213	216
)	217	217
has	219	221
a	223	223
broad	225	229
antibacterial	231	243
spectrum	245	252
against	254	260
Gram	262	265
-	266	266
positive	267	274
and	276	278
Gram	280	283
-	284	284
negative	285	292
bacteria	294	301
;	302	302
especially	304	313
its	315	317
potent	319	324
antibacterial	326	338
activity	340	347
against	349	355
Staphylococcus	357	370
aureus	372	377
is	379	380
a	382	382
significant	384	394
advantage	396	404
that	406	409
may	411	413
not	415	417
be	419	420
found	422	426
with	428	431
other	433	437
cephem	439	444
compounds	446	454
.	455	455

In	457	458
our	460	462
determination	464	476
of	478	479
its	481	483
antibacterial	485	497
potency	499	505
against	507	513
various	515	521
clinical	523	530
isolates	532	539
obtained	541	548
from	550	553
clinical	555	562
materials	564	572
(	574	574
amniotic	575	582
fluid	584	588
,	589	589
intrauterine	591	602
secretions	604	613
,	614	614
exudates	616	623
of	625	626
the	628	630
pelvic	632	637
dead	639	642
space	644	648
)	649	649
of	651	652
patients	654	661
with	663	666
various	668	674
infections	676	685
,	686	686
we	688	689
obtained	691	698
results	700	706
representing	708	719
specific	721	728
features	730	737
of	739	740
this	742	745
drug	747	750
.	751	751

From	753	756
the	758	760
results	762	768
,	769	769
the	771	773
drug	775	778
may	780	782
be	784	785
expected	787	794
to	796	797
produce	799	805
an	807	808
excellent	810	818
effect	820	825
in	827	828
the	830	832
treatment	834	842
of	844	845
various	847	853
infections	855	864
.	865	865

Our	867	869
study	871	875
on	877	878
drug	880	883
concentrations	885	898
in	900	901
body	903	906
fluids	908	913
and	915	917
genital	919	925
tissues	927	933
demonstrated	935	946
a	948	948
good	950	953
transfer	955	962
of	964	965
this	967	970
drug	972	975
into	977	980
various	982	988
tissues	990	996
;	997	997
in	999	1000
every	1002	1006
tissue	1008	1013
examined	1015	1022
,	1023	1023
the	1025	1027
drug	1029	1032
administered	1034	1045
by	1047	1048
the	1050	1052
usual	1054	1058
method	1060	1065
in	1067	1068
the	1070	1072
usual	1074	1078
dose	1080	1083
yielded	1085	1091
a	1093	1093
concentration	1095	1107
exceeding	1109	1117
MIC	1119	1121
for	1123	1125
principal	1127	1135
pathogens	1137	1145
,	1146	1146
thus	1148	1151
promising	1153	1161
a	1163	1163
good	1165	1168
clinical	1170	1177
response	1179	1186
.	1187	1187

Indeed	1189	1194
a	1196	1196
high	1198	1201
clinical	1203	1210
efficacy	1212	1219
rate	1221	1224
of	1226	1227
90	1229	1230
.	1231	1231
1	1232	1232
%	1233	1233
(	1235	1235
good	1236	1239
to	1241	1242
very	1244	1247
good	1249	1252
responses	1254	1262
)	1263	1263
was	1265	1267
obtained	1269	1276
in	1278	1279
a	1281	1281
clinical	1283	1290
trial	1292	1296
involving	1298	1306
222	1308	1310
cases	1312	1316
.	1317	1317

Administration	1319	1332
of	1334	1335
the	1337	1339
drug	1341	1344
in	1346	1347
2	1349	1349
g	1351	1351
quantity	1353	1360
daily	1362	1366
produced	1368	1375
a	1377	1377
high	1379	1382
response	1384	1391
rate	1393	1396
of	1398	1399
92	1401	1402
.	1403	1403
8	1404	1404
%	1405	1405
.	1406	1406

It	1408	1409
was	1411	1413
especially	1415	1424
noteworthy	1426	1435
that	1437	1440
a	1442	1442
good	1444	1447
response	1449	1456
was	1458	1460
obtained	1462	1469
in	1471	1472
30	1474	1475
of	1477	1478
32	1480	1481
cases	1483	1487
(	1489	1489
93	1490	1491
.	1492	1492
8	1493	1493
%	1494	1494
)	1495	1495
in	1497	1498
which	1500	1504
other	1506	1510
cephem	1512	1517
compounds	1519	1527
had	1529	1531
failed	1533	1538
.	1539	1539

In	1541	1542
evaluation	1544	1553
of	1555	1556
the	1558	1560
bacteriological	1562	1576
effect	1578	1583
,	1584	1584
furthermore	1586	1596
,	1597	1597
the	1599	1601
drug	1603	1606
showed	1608	1613
an	1615	1616
excellent	1618	1626
rate	1628	1631
of	1633	1634
bacterial	1636	1644
elimination	1646	1656
.	1657	1657

In	1659	1660
conclusion	1662	1671
,	1672	1672
this	1674	1677
drug	1679	1682
is	1684	1685
expected	1687	1694
to	1696	1697
be	1699	1700
greatly	1702	1708
useful	1710	1715
in	1717	1718
the	1720	1722
light	1724	1728
of	1730	1731
its	1733	1735
good	1737	1740
transfer	1742	1749
into	1751	1754
genital	1756	1762
tissues	1764	1770
and	1772	1774
its	1776	1778
strong	1780	1785
antibacterial	1787	1799
activities	1801	1810
against	1812	1818
Gram	1820	1823
-	1824	1824
positive	1825	1832
cocci	1834	1838
,	1839	1839
Gram	1841	1844
-	1845	1845
negative	1846	1853
bacteria	1855	1862
and	1864	1866
anaerobes	1868	1876
as	1878	1879
well	1881	1884
as	1886	1887
against	1889	1895
multiple	1897	1904
bacterial	1906	1914
infections	1916	1925
predominating	1927	1939
among	1941	1945
women	1947	1951
with	1953	1956
genital	1958	1964
infections	1966	1975
.	1976	1976
